Carlsmed, Inc. (NASDAQ: CARL) Stock Competitors & Peer Comparison
See CARL's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CARL and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CARL | $15.10 | +1.89% | 410.5M | -10.56 | -$1.43 | N/A |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| TEM | $85.01 | +3.37% | 14.9B | -170.02 | -$0.50 | N/A |
| BTSG | $56.59 | +1.02% | 11.1B | 38.50 | $1.47 | N/A |
| BTSGU | $184.31 | -0.16% | 11B | 127.07 | $1.47 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HNGE | $95.57 | +3.90% | 7.4B | 51.07 | $1.87 | N/A |
| HQY | $88.25 | -0.40% | 7.4B | 20.62 | $4.28 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| DOCS | $26.35 | +1.21% | 4.9B | 17.23 | $1.53 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
CARL vs GEHCV Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas GEHCV's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, CARL is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for CARL.Check GEHCV's competition here
Tempus AI, Inc. (NASDAQ: TEM)
CARL vs TEM Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, TEM has a market cap of 14.9B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while TEM trades at $85.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas TEM's P/E ratio is -170.02. In terms of profitability, CARL's ROE is -0.38%, compared to TEM's ROE of -0.55%. Regarding short-term risk, CARL is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for CARL.Check TEM's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
CARL vs BTSG Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, BTSG has a market cap of 11.1B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while BTSG trades at $56.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas BTSG's P/E ratio is 38.50. In terms of profitability, CARL's ROE is -0.38%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, CARL is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for CARL.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
CARL vs BTSGU Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, BTSGU has a market cap of 11B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while BTSGU trades at $184.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas BTSGU's P/E ratio is 127.07. In terms of profitability, CARL's ROE is -0.38%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, CARL is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for CARL.Check BTSGU's competition here
Signify Health, Inc. (NYSE: SGFY)
CARL vs SGFY Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas SGFY's P/E ratio is 70.91. In terms of profitability, CARL's ROE is -0.38%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, CARL is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for CARL.Check SGFY's competition here
Hinge Health, Inc. (NYSE: HNGE)
CARL vs HNGE Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, HNGE has a market cap of 7.4B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while HNGE trades at $95.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas HNGE's P/E ratio is 51.07. In terms of profitability, CARL's ROE is -0.38%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, CARL is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for CARL.Check HNGE's competition here
HealthEquity, Inc. (NASDAQ: HQY)
CARL vs HQY Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, HQY has a market cap of 7.4B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while HQY trades at $88.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas HQY's P/E ratio is 20.62. In terms of profitability, CARL's ROE is -0.38%, compared to HQY's ROE of +0.11%. Regarding short-term risk, CARL is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for CARL.Check HQY's competition here
R1 RCM Inc. (NASDAQ: RCM)
CARL vs RCM Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas RCM's P/E ratio is -102.21. In terms of profitability, CARL's ROE is -0.38%, compared to RCM's ROE of +0.00%. Regarding short-term risk, CARL is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for CARL.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
CARL vs DOCS Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, DOCS has a market cap of 4.9B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while DOCS trades at $26.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas DOCS's P/E ratio is 17.23. In terms of profitability, CARL's ROE is -0.38%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, CARL is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for CARL.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
CARL vs WAY Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, WAY has a market cap of 4.7B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while WAY trades at $24.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas WAY's P/E ratio is 16.36. In terms of profitability, CARL's ROE is -0.38%, compared to WAY's ROE of +0.04%. Regarding short-term risk, CARL is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for CARL.Check WAY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
CARL vs HTFL Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, HTFL has a market cap of 4.2B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while HTFL trades at $49.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas HTFL's P/E ratio is -24.46. In terms of profitability, CARL's ROE is -0.38%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, CARL is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for CARL.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
CARL vs ONEM Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas ONEM's P/E ratio is -7.77. In terms of profitability, CARL's ROE is -0.38%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, CARL is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for CARL.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
CARL vs PRVA Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, PRVA has a market cap of 2.5B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while PRVA trades at $19.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas PRVA's P/E ratio is 93.86. In terms of profitability, CARL's ROE is -0.38%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, CARL is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for CARL.Check PRVA's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
CARL vs NXGN Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas NXGN's P/E ratio is -266.00. In terms of profitability, CARL's ROE is -0.38%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, CARL is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for CARL.Check NXGN's competition here
Omnicell, Inc. (NASDAQ: OMCL)
CARL vs OMCL Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, OMCL has a market cap of 1.5B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while OMCL trades at $33.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas OMCL's P/E ratio is 17.62. In terms of profitability, CARL's ROE is -0.38%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, CARL is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for CARL.Check OMCL's competition here
Certara, Inc. (NASDAQ: CERT)
CARL vs CERT Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, CERT has a market cap of 1.4B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while CERT trades at $9.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas CERT's P/E ratio is 22.78. In terms of profitability, CARL's ROE is -0.38%, compared to CERT's ROE of -0.07%. Regarding short-term risk, CARL is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for CARL.Check CERT's competition here
Agiliti, Inc. (NYSE: AGTI)
CARL vs AGTI Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas AGTI's P/E ratio is -71.79. In terms of profitability, CARL's ROE is -0.38%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, CARL is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for CARL.Check AGTI's competition here
Omada Health (NASDAQ: OMDA)
CARL vs OMDA Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, OMDA has a market cap of 1.2B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while OMDA trades at $19.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas OMDA's P/E ratio is 280.86. In terms of profitability, CARL's ROE is -0.38%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, CARL is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for CARL.Check OMDA's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
CARL vs GDRX Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while GDRX trades at $3.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas GDRX's P/E ratio is 10.47. In terms of profitability, CARL's ROE is -0.38%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, CARL is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for CARL.Check GDRX's competition here
Teladoc Health, Inc. (NYSE: TDOC)
CARL vs TDOC Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, TDOC has a market cap of 1.1B. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while TDOC trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas TDOC's P/E ratio is -6.14. In terms of profitability, CARL's ROE is -0.38%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, CARL is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for CARL.Check TDOC's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
CARL vs CCLDO Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas CCLDO's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, CARL is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for CARL.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
CARL vs HSTM Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, HSTM has a market cap of 850.2M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while HSTM trades at $29.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas HSTM's P/E ratio is 40.42. In terms of profitability, CARL's ROE is -0.38%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, CARL is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for CARL.Check HSTM's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
CARL vs SOPH Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, SOPH has a market cap of 699.7M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while SOPH trades at $8.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas SOPH's P/E ratio is -7.51. In terms of profitability, CARL's ROE is -0.38%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, CARL is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for CARL.Check SOPH's competition here
Phreesia, Inc. (NYSE: PHR)
CARL vs PHR Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, PHR has a market cap of 628M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while PHR trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas PHR's P/E ratio is 36.29. In terms of profitability, CARL's ROE is -0.38%, compared to PHR's ROE of +0.03%. Regarding short-term risk, CARL is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for CARL.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
CARL vs MPLN-WT Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, CARL is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for CARL.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
CARL vs ACCD Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas ACCD's P/E ratio is -3.08. In terms of profitability, CARL's ROE is -0.38%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, CARL is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for CARL.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
CARL vs SHCR Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas SHCR's P/E ratio is -3.76. In terms of profitability, CARL's ROE is -0.38%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, CARL is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for CARL.Check SHCR's competition here
NRC Health (NASDAQ: NRC)
CARL vs NRC Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, NRC has a market cap of 441M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while NRC trades at $19.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas NRC's P/E ratio is 23.87. In terms of profitability, CARL's ROE is -0.38%, compared to NRC's ROE of +0.48%. Regarding short-term risk, CARL is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for CARL.Check NRC's competition here
Evolent Health, Inc. (NYSE: EVH)
CARL vs EVH Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, EVH has a market cap of 406.6M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while EVH trades at $3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas EVH's P/E ratio is 27.81. In terms of profitability, CARL's ROE is -0.38%, compared to EVH's ROE of -0.99%. Regarding short-term risk, CARL is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for CARL.Check EVH's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
CARL vs SLGC Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas SLGC's P/E ratio is -3.04. In terms of profitability, CARL's ROE is -0.38%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, CARL is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for CARL.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
CARL vs SLGCW Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, CARL's ROE is -0.38%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, CARL is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for CARL.Check SLGCW's competition here
Claritev Corporation (NYSE: CTEV)
CARL vs CTEV Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, CTEV has a market cap of 396M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while CTEV trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas CTEV's P/E ratio is -1.37. In terms of profitability, CARL's ROE is -0.38%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, CARL is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for CARL.Check CTEV's competition here
TruBridge, Inc. (NASDAQ: TBRG)
CARL vs TBRG Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas TBRG's P/E ratio is 9.37. In terms of profitability, CARL's ROE is -0.38%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, CARL is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for CARL.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
CARL vs MPLN Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas MPLN's P/E ratio is -0.23. In terms of profitability, CARL's ROE is -0.38%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, CARL is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for CARL.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
CARL vs SY Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, SY has a market cap of 354.3M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while SY trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas SY's P/E ratio is -8.18. In terms of profitability, CARL's ROE is -0.38%, compared to SY's ROE of -0.16%. Regarding short-term risk, CARL is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for CARL.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
CARL vs TRHC Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas TRHC's P/E ratio is -4.27. In terms of profitability, CARL's ROE is -0.38%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, CARL is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for CARL.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
CARL vs SMFR Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas SMFR's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, CARL is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for CARL.Check SMFR's competition here
American Well Corporation (NYSE: AMWL)
CARL vs AMWL Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, AMWL has a market cap of 227.6M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while AMWL trades at $13.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas AMWL's P/E ratio is -3.03. In terms of profitability, CARL's ROE is -0.38%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, CARL is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for CARL.Check AMWL's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
CARL vs SPOK Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, SPOK has a market cap of 218.5M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while SPOK trades at $10.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas SPOK's P/E ratio is 17.43. In terms of profitability, CARL's ROE is -0.38%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, CARL is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for CARL.Check SPOK's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
CARL vs LFMDP Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, LFMDP has a market cap of 157.2M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while LFMDP trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas LFMDP's P/E ratio is -710.63. In terms of profitability, CARL's ROE is -0.38%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, CARL is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for CARL.Check LFMDP's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
CARL vs OPRX Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, OPRX has a market cap of 150.9M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while OPRX trades at $8.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas OPRX's P/E ratio is 7.38. In terms of profitability, CARL's ROE is -0.38%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, CARL is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for CARL.Check OPRX's competition here
LifeMD, Inc. (NASDAQ: LFMD)
CARL vs LFMD Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, LFMD has a market cap of 143.6M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while LFMD trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas LFMD's P/E ratio is -5.94. In terms of profitability, CARL's ROE is -0.38%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, CARL is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for CARL.Check LFMD's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
CARL vs CPSI Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas CPSI's P/E ratio is -183.80. In terms of profitability, CARL's ROE is -0.38%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, CARL is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for CARL.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
CARL vs HCAT Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, HCAT has a market cap of 128.6M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while HCAT trades at $1.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas HCAT's P/E ratio is 8.70. In terms of profitability, CARL's ROE is -0.38%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, CARL is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for CARL.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
CARL vs AUGX Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas AUGX's P/E ratio is -4.99. In terms of profitability, CARL's ROE is -0.38%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, CARL is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for CARL.Check AUGX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
CARL vs DH Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, DH has a market cap of 99.7M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while DH trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas DH's P/E ratio is 3.63. In terms of profitability, CARL's ROE is -0.38%, compared to DH's ROE of -0.79%. Regarding short-term risk, CARL is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for CARL.Check DH's competition here
SCWorx Corp. (NASDAQ: WORX)
CARL vs WORX Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, WORX has a market cap of 88M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas WORX's P/E ratio is -6.40. In terms of profitability, CARL's ROE is -0.38%, compared to WORX's ROE of -0.35%. Regarding short-term risk, CARL is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for CARL.Check WORX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
CARL vs CCLD Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, CCLD has a market cap of 87.1M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while CCLD trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas CCLD's P/E ratio is 7.88. In terms of profitability, CARL's ROE is -0.38%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, CARL is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for CARL.Check CCLD's competition here
Forian Inc. (NASDAQ: FORA)
CARL vs FORA Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas FORA's P/E ratio is -24.11. In terms of profitability, CARL's ROE is -0.38%, compared to FORA's ROE of -0.17%. Regarding short-term risk, CARL is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for CARL.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
CARL vs CCLDP Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas CCLDP's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, CARL is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for CARL.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
CARL vs ONMD Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, ONMD has a market cap of 37M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while ONMD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas ONMD's P/E ratio is -4.06. In terms of profitability, CARL's ROE is -0.38%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, CARL is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for CARL.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
CARL vs SNCE Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas SNCE's P/E ratio is -0.27. In terms of profitability, CARL's ROE is -0.38%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, CARL is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for CARL.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
CARL vs AKLI Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas AKLI's P/E ratio is -0.71. In terms of profitability, CARL's ROE is -0.38%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, CARL is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for CARL.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
CARL vs SHLT Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas SHLT's P/E ratio is -3.87. In terms of profitability, CARL's ROE is -0.38%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, CARL is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for CARL.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
CARL vs SHCRW Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, CARL's ROE is -0.38%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, CARL is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for CARL.Check SHCRW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
CARL vs STRM Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas STRM's P/E ratio is -2.40. In terms of profitability, CARL's ROE is -0.38%, compared to STRM's ROE of -0.65%. Regarding short-term risk, CARL is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for CARL.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
CARL vs RNLX Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas RNLX's P/E ratio is -0.33. In terms of profitability, CARL's ROE is -0.38%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, CARL is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for CARL.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
CARL vs LIFW Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas LIFW's P/E ratio is -0.02. In terms of profitability, CARL's ROE is -0.38%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, CARL is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for CARL.Check LIFW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
CARL vs ONMDW Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, ONMDW has a market cap of 22.3M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas ONMDW's P/E ratio is -0.16. In terms of profitability, CARL's ROE is -0.38%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, CARL is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for CARL.Check ONMDW's competition here
Babylon Holdings Limited (NYSE: BBLN)
CARL vs BBLN Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas BBLN's P/E ratio is -0.04. In terms of profitability, CARL's ROE is -0.38%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, CARL is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for CARL.Check BBLN's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
CARL vs BFRG Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, BFRG has a market cap of 12.3M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while BFRG trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas BFRG's P/E ratio is -1.45. In terms of profitability, CARL's ROE is -0.38%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, CARL is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for CARL.Check BFRG's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
CARL vs HCTI Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, HCTI has a market cap of 11.7M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while HCTI trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas HCTI's P/E ratio is -0.10. In terms of profitability, CARL's ROE is -0.38%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, CARL is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for CARL.Check HCTI's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
CARL vs ETAO Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas ETAO's P/E ratio is -0.01. In terms of profitability, CARL's ROE is -0.38%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, CARL is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for CARL.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
CARL vs MGRX Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, MGRX has a market cap of 7.9M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while MGRX trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas MGRX's P/E ratio is -0.35. In terms of profitability, CARL's ROE is -0.38%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, CARL is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for CARL.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH-WT)
CARL vs UPH-WT Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, CARL is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for CARL.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
CARL vs UPH Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas UPH's P/E ratio is -0.07. In terms of profitability, CARL's ROE is -0.38%, compared to UPH's ROE of -1.05%. Regarding short-term risk, CARL is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for CARL.Check UPH's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
CARL vs PEAR Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas PEAR's P/E ratio is -0.08. In terms of profitability, CARL's ROE is -0.38%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, CARL is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for CARL.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
CARL vs PEARW Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas PEARW's P/E ratio is -0.00. In terms of profitability, CARL's ROE is -0.38%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, CARL is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for CARL.Check PEARW's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
CARL vs BFRGW Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, BFRGW has a market cap of 2.4M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while BFRGW trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas BFRGW's P/E ratio is -0.40. In terms of profitability, CARL's ROE is -0.38%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, CARL is less volatile compared to BFRGW. This indicates lower risk in terms of short-term price fluctuations for CARL.Check BFRGW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
CARL vs OTRK Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas OTRK's P/E ratio is -0.02. In terms of profitability, CARL's ROE is -0.38%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, CARL is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for CARL.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
CARL vs CMAX Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas CMAX's P/E ratio is -0.00. In terms of profitability, CARL's ROE is -0.38%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, CARL is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for CARL.Check CMAX's competition here
Aclarion, Inc. (NASDAQ: ACON)
CARL vs ACON Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, ACON has a market cap of 1.4M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while ACON trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas ACON's P/E ratio is -0.29. In terms of profitability, CARL's ROE is -0.38%, compared to ACON's ROE of -0.59%. Regarding short-term risk, CARL is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for CARL.Check ACON's competition here
VSee Health, Inc. (NASDAQ: VSEE)
CARL vs VSEE Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, VSEE has a market cap of 1.3M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while VSEE trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas VSEE's P/E ratio is -4.02. In terms of profitability, CARL's ROE is -0.38%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, CARL is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for CARL.Check VSEE's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
CARL vs LIFWZ Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, CARL is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for CARL.Check LIFWZ's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
CARL vs VSEEW Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, CARL's ROE is -0.38%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, CARL is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for CARL.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
CARL vs MSPRZ Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, CARL is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for CARL.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERNW)
CARL vs KERNW Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas KERNW's P/E ratio is -0.00. In terms of profitability, CARL's ROE is -0.38%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, CARL is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for CARL.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
CARL vs KERN Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas KERN's P/E ratio is -0.01. In terms of profitability, CARL's ROE is -0.38%, compared to KERN's ROE of -0.20%. Regarding short-term risk, CARL is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for CARL.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
CARL vs LIFWW Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas LIFWW's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, CARL is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for CARL.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
CARL vs CMAXW Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas CMAXW's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, CARL is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for CARL.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
CARL vs ZCMD Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, ZCMD has a market cap of 32K. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while ZCMD trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, CARL's ROE is -0.38%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, CARL is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for CARL.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
CARL vs ACONW Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, ACONW has a market cap of 13.7K. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas ACONW's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, CARL is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for CARL.Check ACONW's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
CARL vs SMFRW Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas SMFRW's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, CARL is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for CARL.Check SMFRW's competition here
NantHealth, Inc. (NASDAQ: NH)
CARL vs NH Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, NH has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas NH's P/E ratio is -0.12. In terms of profitability, CARL's ROE is -0.38%, compared to NH's ROE of +0.35%. Regarding short-term risk, CARL is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for CARL.Check NH's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
CARL vs AFFX Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas AFFX's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, CARL is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for CARL.Check AFFX's competition here
CareCloud, Inc. (NASDAQ: MTBC)
CARL vs MTBC Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas MTBC's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, CARL is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for CARL.Check MTBC's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
CARL vs NAVA Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas NAVA's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, CARL is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for CARL.Check NAVA's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
CARL vs MTBCO Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas MTBCO's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, CARL is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for CARL.Check MTBCO's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
CARL vs IMS Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, IMS has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas IMS's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to IMS's ROE of +0.27%. Regarding short-term risk, CARL is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for CARL.Check IMS's competition here
Castlight Health, Inc. (NYSE: CSLT)
CARL vs CSLT Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas CSLT's P/E ratio is -37.27. In terms of profitability, CARL's ROE is -0.38%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, CARL is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for CARL.Check CSLT's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
CARL vs CNVY Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas CNVY's P/E ratio is -71.50. In terms of profitability, CARL's ROE is -0.38%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, CARL is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for CARL.Check CNVY's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
CARL vs KURIU Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas KURIU's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, CARL is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for CARL.Check KURIU's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
CARL vs CHNGU Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas CHNGU's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, CARL is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for CARL.Check CHNGU's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
CARL vs MTBCP Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas MTBCP's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, CARL is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for CARL.Check MTBCP's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
CARL vs MSPRV Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas MSPRV's P/E ratio is N/A. In terms of profitability, CARL's ROE is -0.38%, compared to MSPRV's ROE of N/A. Regarding short-term risk, CARL is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for CARL.Check MSPRV's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
CARL vs CHNG Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas CHNG's P/E ratio is -152.72. In terms of profitability, CARL's ROE is -0.38%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, CARL is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for CARL.Check CHNG's competition here
Cerner Corporation (NASDAQ: CERN)
CARL vs CERN Comparison September 2026
Carlsmed, Inc. (NASDAQ: CARL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CARL stands at 410.5M. In comparison, CERN has a market cap of 0. Regarding current trading prices, CARL is priced at $15.10 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CARL currently has a P/E ratio of -10.56, whereas CERN's P/E ratio is 55.84. In terms of profitability, CARL's ROE is -0.38%, compared to CERN's ROE of +0.14%. Regarding short-term risk, CARL is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for CARL.Check CERN's competition here